Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Neurology, Orthopedic, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Orthopedics / Podiatry, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | February 2014 |
| End Date: | November 2015 |
Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation on Walking and Cortical Activation in Patients With Multiple Sclerosis.
Rhythmic Auditory Stimulation (RAS) is a music therapy technique that provides rhythmic
auditory cues (like a beat) to help improve patients' movements, especially when walking.
The purpose of this study is to compare the effect on walking performance of a home based
walking program (HBWP) with Rhythmic Auditory Stimulation (RAS), to that of a HBWP without
RAS, or to RAS without walking exercise.
A second part of this study will assess the effects of Rhythmic Auditory Stimulation (RAS)
on brain activity in patients with Multiple Sclerosis while performing mental imagery of
walking.
auditory cues (like a beat) to help improve patients' movements, especially when walking.
The purpose of this study is to compare the effect on walking performance of a home based
walking program (HBWP) with Rhythmic Auditory Stimulation (RAS), to that of a HBWP without
RAS, or to RAS without walking exercise.
A second part of this study will assess the effects of Rhythmic Auditory Stimulation (RAS)
on brain activity in patients with Multiple Sclerosis while performing mental imagery of
walking.
Inclusion Criteria:
1. age 18 years or older
2. diagnosis of MS per Mc Donald criteria
3. Ambulation Index score from 2 to 6 inclusive (clinically observable gait disturbance,
whether the subject walks with no, unilateral, or bilateral support)
4. spastic paresis is the main neurologic impairment causing the gait disturbance, per
investigator's judgment.
Exclusion Criteria:
1. neurologic impairments other than spastic paresis (e.g. cerebellar ataxia or sensory
ataxia), or non-neurologic impairments (e.g. musculoskeletal problems) play a major
role in the subject's gait disturbance, per investigator's judgment;
2. treatment for an MS exacerbation in the past 30 days;
3. severe co morbidity precluding participation in the study per investigator's judgment
(e.g. severe cardiac or respiratory failure);
4. severe cognitive deficits precluding informed consent or preventing the subject from
following study procedures safely
5. contraindication to MRI such as severe claustrophobia and implanted devices such as
neurostimulators, pacemakers, aneurysm clips etc.
6. pregnancy.
We found this trial at
1
site
Click here to add this to my saved trials
